FIGURE

Figure 1

ID
ZDB-FIG-210411-36
Publication
Zallocchi et al., 2021 - Characterization of quinoxaline derivatives for protection against iatrogenic-induced hearing loss
Other Figures
All Figure Page
Back to All Figure Page
Figure 1

Screening of quinoxaline derivatives. Five dpf Tg(brn3c:GFP) zebrafish were preincubated with quinoxaline (Qx, 300 μM) or its derivatives (Qx2–Qx70, 10 nM–300 μM) for 1 hour, followed by coincubation with neomycin (Neo) 200 μM for 30 minutes (A) or gentamicin (GM) 100 μM long-term effect (B). Hair cells were quantified employing a Zeiss AxioSkop 2 fluorescence microscope with a 40× oil objective. White dot, vehicle; blue dot, ototoxin alone; gray dot, quinoxaline 300 μM. Black dots, quinoxaline derivatives that did not show any significant differences compared with ototoxin alone. Yellow dots, quinoxaline derivatives that performed significantly better than ototoxin alone but not significantly different from quinoxaline treatment. Red dots, quinoxaline derivatives that performed significantly better than quinoxaline treatment. Results were expressed as mean ± SEM. Statistical analysis: 1-way ANOVA with correction for Dunnett’s multiple comparisons test. Significance was set at P < 0.05 versus ototoxin or quinoxaline. Six fish were used per treatment, and 3 neuromasts were inspected per fish (n = 18).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Conditions:
Observed In:
Stage: Day 5

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ JCI Insight